What is the recommended dosage and treatment duration for Temazepam (temazepam) in patients with insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Temazepam Dosing and Treatment Duration for Insomnia

For adults with insomnia, start with temazepam 15 mg at bedtime, which is the recommended initial dose that balances efficacy with minimal adverse effects, and limit treatment to 7-10 days for short-term insomnia. 1

Initial Dosing Strategy

  • Begin with 15 mg at bedtime for most adults, as this dose increases total sleep time by approximately 64-99 minutes compared to placebo and improves sleep efficiency by 13-14% 2, 3
  • Use 7.5 mg for elderly or debilitated patients until individual responses are determined 1
  • For transient insomnia specifically, 7.5 mg may be sufficient to improve sleep latency and is clinically equivalent to 15 mg 1, 4

Dose Titration

  • If 15 mg is insufficient, increase to 30 mg for patients requiring greater symptom control 1
  • The 20 mg dose reduces sleep latency by 23-29 minutes and increases total sleep time by 18-78 minutes versus placebo 2, 3
  • The 30 mg dose increases total sleep time by 53-55 minutes and reduces awakenings by 1.0-1.24 episodes compared to placebo 2, 3

Treatment Duration

Limit temazepam to 7-10 days for short-term insomnia treatment, as this is the FDA-approved duration and the timeframe supported by clinical trial data 1

  • The efficacy trials supporting temazepam were 2 weeks in duration, with formal assessment at end of treatment 1
  • For elderly patients, an 8-week study showed temazepam remained safe with few adverse effects, though this exceeds standard recommendations 5
  • After initial short-term use, employ intermittent dosing as needed rather than continuous nightly administration 6

Adverse Effect Profile by Dose

  • 15 mg shows no notable increase in adverse effects versus placebo with minimal daytime impairment 2, 3
  • 20 mg has modest increases in headache, blurred vision, depression, and confusion, though overall frequency remains low 2, 3
  • 30 mg carries higher risk of drowsiness, lethargy, vertigo, and daytime psychomotor impairment 2, 3

Critical Discontinuation Protocol

Use gradual tapering when discontinuing temazepam to prevent withdrawal reactions 1

  • If withdrawal symptoms develop, pause the taper or increase back to the previous dose level 1
  • Subsequently decrease more slowly to minimize risk 1

Important Clinical Considerations

  • Temazepam is absorbed slowly (peak at 2-3 hours) and may not consistently reduce sleep onset latency when taken at bedtime 7, 8
  • The drug is most effective for sleep maintenance rather than sleep initiation, making it appropriate for patients with middle-of-night or early morning awakening 9, 7
  • In elderly patients (7.5 mg dose), total wake time improved from 145 to 100 minutes with short-term use, with no rebound insomnia upon withdrawal 6
  • For patients with addiction history, consider alternative medications like ramelteon rather than benzodiazepines 3

References

Guideline

Temazepam Dosing and Efficacy for Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Restoril (Temazepam) Dosing and Efficacy in Insomnia Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Temazepam 7.5 mg: effects on sleep in elderly insomniacs.

European journal of clinical pharmacology, 1994

Research

Evaluation of temazepam as a hypnotic.

Pharmacotherapy, 1981

Research

Temazepam (Restoril, Sandoz Pharmaceuticals).

Drug intelligence & clinical pharmacy, 1982

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.